OFS (OFS Capital Corporation) Stock Analysis - News
OFS Capital Corporation (OFS) is a publicly traded Financial Services sector company. As of May 21, 2026, OFS trades at $3.37 with a market cap of $44.62M and a P/E ratio of -0.93. OFS moved +1.36% today. Year to date, OFS is -30.37%; over the trailing twelve months it is -61.31%. Its 52-week range spans $2.72 to $9.80. Rallies surfaces OFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in OFS news today?
OFS Capital Reports 7.52% Net Margin, Analysts See 39.7% Upside to $7 Target: OFS Capital reported a net margin of 7.52%, ROE of 8.95% and ROA of 3.41%, significantly outperforming Advanced Medical Isotope’s -6,144.90% net margin and -113.56% ROA. Analysts assign OFS Capital a $7.00 consensus price target implying 39.7% upside and rate it 1.50 versus RDGL’s 0.00.
Porter Mukya bought 210 (~$1.19K) on Nov 17, 2020.
Owen Jeffery S. bought 11.95K (~$69.19K) on Nov 16, 2020.
Owen Jeffery S. bought 2.55K (~$13.18K) on Nov 13, 2020.
OFS Analyst Consensus
OFS analyst coverage data. Average price target: $0.00.
Common questions about OFS
What changed in OFS news today?
OFS Capital Reports 7.52% Net Margin, Analysts See 39.7% Upside to $7 Target: OFS Capital reported a net margin of 7.52%, ROE of 8.95% and ROA of 3.41%, significantly outperforming Advanced Medical Isotope’s -6,144.90% net margin and -113.56% ROA. Analysts assign OFS Capital a $7.00 consensus price target implying 39.7% upside and rate it 1.50 versus RDGL’s 0.00.
Does Rallies summarize OFS news?
Yes. Rallies summarizes OFS news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is OFS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OFS. It does not provide personalized investment advice.
